{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Parecoxib as an Analgesic Adjuvant in Brachial Plexus Nerve Block"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this randomised controlled trial, 150 patients scheduled for elective forearm surgery were recruited from January 2009 to November 2010."
      },
      "Participants": {
        "score": 2,
        "evidence": "150 patients scheduled for elective forearm surgery were recruited from January 2009 to November 2010."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Group A (n=50) received ropivacaine 0.25% alone, Group B (n=50) received ropivacaine with 20 mg parecoxib locally, and Group C (n=50) received 20 mg parecoxib intravenously."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the effect of parecoxib, a COX-2 antagonist, on sensory and motor block times when added to ropivacaine in brachial plexus nerve blocks."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the duration of sensory and motor blocks, measured over 24 hours postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "150 patients scheduled for elective forearm surgery were recruited from January 2009 to November 2010."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Group A (n=50) received ropivacaine 0.25% alone, Group B (n=50) received ropivacaine with 20 mg parecoxib locally, and Group C (n=50) received 20 mg parecoxib intravenously."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Group B showed prolonged motor and sensory block times compared to Group A (mean difference = X hours, 95% CI Y to Z; p < 0.05)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Registration Number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of Funding]."
      }
    },
    "total_score": 19,
    "max_score": 25
  },
  "model": "gpt-4o"
}